相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists
Amer H. Tarawneh et al.
ARABIAN JOURNAL OF CHEMISTRY (2022)
Role of Shankhpushpi (Convolvulus pluricaulis) in neurological disorders: An umbrella review covering evidence from ethnopharmacology to clinical studies
Ruchi Sharma et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2022)
Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge
Omar Soler-Cedeno et al.
CELLS (2022)
Anti-obesity therapy with peripheral CB1 blockers: from promise to safe(?) practice
Carmelo Quarta et al.
INTERNATIONAL JOURNAL OF OBESITY (2020)
4-O-Methylhonokiol Influences Normal Cardiovascular Development in Medaka Embryo
Santu K. Singha et al.
MOLECULES (2019)
Antidepressant-Like Effect and Mechanism of Action of Honokiol on the Mouse Lipopolysaccharide (LPS) Depression Model
Bo Zhang et al.
MOLECULES (2019)
Antifungal Effect of Magnolol and Honokiol from Magnolia officinalis on Alternaria alternata Causing Tobacco Brown Spot
Ya-Han Chen et al.
MOLECULES (2019)
Crystal Structure of the Human Cannabinoid Receptor CB2
Xiaoting Li et al.
CELL (2019)
Selective Cannabinoid 2 Receptor Stimulation Reduces Tubular Epithelial Cell Damage after Renal Ischemia-Reperfusion Injury
Jeffrey D. Pressly et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Safety and Toxicology of Magnolol and Honokiol
Andrea Sarrica et al.
PLANTA MEDICA (2018)
Antihyperalgesic Properties of Honokiol in Inflammatory Pain Models by Targeting of NF-κB and Nrf2 Signaling
Sidra Khalid et al.
FRONTIERS IN PHARMACOLOGY (2018)
Bioinspired Honokiol Analogs and Their Evaluation for Activity on the Norepinephrine Transporter
Kristen Stout et al.
MOLECULES (2018)
Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse Agonists
Pankaj Pandey et al.
MOLECULES (2018)
Is there a potential of misuse for Magnolia officinalis compounds/metabolites?
Fabrizio Schifano et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2017)
Crystal structures of agonist-bound human cannabinoid receptor CB1
Tian Hua et al.
NATURE (2017)
Trends in GPCR drug discovery: new agents, targets and indications
Alexander S. Hauser et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
Edward Harder et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics
Tuan Trang et al.
JOURNAL OF NEUROSCIENCE (2015)
Structural analogues of the natural products magnolol and honokiol as potent allosteric potentiators of GABAA receptors
Alexander Fuchs et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Evaluation of phytocannabinoids from high-potency Cannabis sativa using in vitro bioassays to determine structure-activity relationships for cannabinoid receptor 1 and cannabinoid receptor 2
Afeef S. Husni et al.
MEDICINAL CHEMISTRY RESEARCH (2014)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
Sangdon Han et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Heteroatom Analogues of Hydrocodone: Synthesis and Biological Activity
Robert D. Giacometti et al.
JOURNAL OF ORGANIC CHEMISTRY (2013)
Biphenyl-type neolignans from Magnolia officinalis and their anti-inflammatory activities
Wen-Lung Kuo et al.
PHYTOCHEMISTRY (2013)
The Natural Product Magnolol as a Lead Structure for the Development of Potent Cannabinoid Receptor Agonists
Alexander Fuchs et al.
PLOS ONE (2013)
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55
Viktor Rempel et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
The case for peripheral CB1 receptor blockade in the treatment of visceral obesity and its cardiometabolic complications
George Kunos et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Mechanisms of Osteoclastogenesis Inhibition by a Novel Class of Biphenyl-Type Cannabinoid CB2 Receptor Inverse Agonists
Wolfgang Schuehly et al.
CHEMISTRY & BIOLOGY (2011)
Cannabinoid-Opioid Interaction in Chronic Pain
D. I. Abrams et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Anxiolytic-Like Effects of 4-O-Methylhonokiol Isolated from Magnolia officinalis Through Enhancement of GABAergic Transmission and Chloride Influx
Huishan Han et al.
JOURNAL OF MEDICINAL FOOD (2011)
Therapeutic applications of compounds in the Magnolia family
Young-Jung Lee et al.
PHARMACOLOGY & THERAPEUTICS (2011)
ISOLATION AND PURIFICATION OF PHENOLIC COMPOUNDS FROM MAGNOLIAE OFFICINALIS BY PREPARATIVE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
Xia Liu et al.
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES (2010)
The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy
Nicole Defer et al.
FASEB JOURNAL (2009)
Neolignans from North American Magnolia Species with Cyclooxygenase 2 Inhibitory Activity
W. Schühly et al.
INFLAMMOPHARMACOLOGY (2009)
The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration
John C. Ashton et al.
CURRENT NEUROPHARMACOLOGY (2007)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Inhibition of MAO A and B by some plant-derived alkaloids, phenols and anthraquinones
LD Kong et al.
JOURNAL OF ETHNOPHARMACOLOGY (2004)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
On the role of the crystal environment in determining protein side-chain conformations
MP Jacobson et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
分享论文
